Tearlab Corp. (TEAR) Misses Q1 EPS by 1c, Lowers FY Rev Guidance

Tearlab Corp. (NASDAQ: TEAR) reported Q1 EPS of ($0.17), $0.01 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $5 million versus the consensus estimate of $5.12 million.

Tearlab Corp. sees FY2014 revenue of $22-23 million, versus prior guidance of $30-33 million and the consensus of $25.70 million.

For earnings history and earnings-related data on Tearlab Corp. (TEAR) click here.

You May Also Be Interested In

• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
• Eton Pharmaceuticals Inc. (ETON) Tops Q2 EPS by 28c, Raises Guidance
• Metalla Royalty & Streaming Ltd. (MTA) Reports In-Line Q2 EPS